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Abstract: Biodegradable polymer particles present a promising approach for intracellular 
delivery of drugs, proteins, and nucleic acids. Poly-d,l-lactide-poly(ethylene glycol) (PELA) 
copolymers with different weight ratios of polyethylene glycol (PEG) were used as drug car-
riers in the present study. PELA particles entrapped with fluorescein isothiocyanate (FITC) as 
a fluorescent marker were formulated using a double emulsion-solvent evaporation technique. 
The size and morphology of the particles were observed with scanning electron microscope 
(SEM), atomic force microscope (AFM), and laser diffraction particle size analyzer (LDPSA). 
The purpose in the present work was to investigate the cytotoxicity and the process of endo-
cytosis of PELA particles with different contents of PEG and variable particle size using rat 
osteoblasts (OBs). The cytotoxicity of the particles was investigated using 5-dimethylthiazol-
2-yl-2,5-diphenyltetrazolium bromide (MTT) assay and flow cytometry. Results indicate that 
as the content of PEG in the polymer increased, so did cell survival. Endocytosis was observed 
through a light microscope and a fluorescence microscope; intracellular uptake and retention 
were determined quantitatively using fluorescence spectrophotometer (FSP). The results showed 
that as PEG content in PELA copolymer increased, there was a reduction in endocytosis of 
nanoparticles in osteoblasts.
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With the development of modern medicine and pharmacology, gene therapy becomes of 
increasing concern in the treatment of bone disease because it can increase therapeutic 
effects. Modern nanotechnology allows for a variety of choices in developing efﬁcient 
systems for delivering diverse therapeutic agents ranging from small molecule drugs to 
biomacromolecules (eg, recombinant proteins, genes).1 Most of these therapeutic agents 
require intracellular uptake to deliver their therapeutic effect because their site of action 
is within the cell. However, the major limitation with macromolecular therapeutics is 
their inefﬁcient intracellular uptake and susceptibility to degradation during uptake by 
endocytosis.2 Endocytosis is a conserved process in eukaryotes whereby extracellular 
substances are taken up into the cells usually by the invagination of plasma membrane 
forming vesicles. In addition to the classical clathrin- (or receptor-) mediated pathway, 
other endocytic mechanisms have been identiﬁed: phagocytosis, caveolae-mediated 
endocytosis, macropinocytosis, and clathrin- and caveolae-independent endocytosis.3–5 
These various endocytic routes vary in the composition of coat, size of detached 
vesicles, and fate of internalized material.4–6
Development of nanoparticles as an efﬁcient carrier for intracellular drug and 
macromolecular delivery is dependent on their efﬁcient internalization and sustained International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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retention inside the cell and drug activity. Over the past 
two decades, there has been a steady rise in the number of 
commercially available nanoparticle (NP) therapeutics.7–9 
Several reports have included discussions of the internaliza-
tion of polymeric nanoparticles into the cells by endocytic 
pathways.10–12 Biodegradable polymers such as poly(d,l-lactic 
acid) (PLA), poly(d,l-lactic-co-glycolic acid) (PLGA), and 
poly(ε-caprolactone) and their diblocked or multiblocked 
copolymers with PEG have been commonly used to form 
core – shell structured NPs to encapsulate a variety of thera-
peutic compounds.13–20 It has been shown that biodegradable 
nanoparticles formulated from PLGA rapidly escape the 
degradative endo-lysosomal compartment and are capable 
of delivering a variety of payloads into the cytoplasm.21–23 
PLGA nanoparticles for delivery of therapeutics are of par-
ticular interest due to their biocompatibility, biodegradability, 
and ability to maintain therapeutic drug levels for sustained 
periods of time. The polymer matrix prevents the degradation 
of the drug and the duration and levels of drug released from 
the NPs can be easily modulated by altering the formulation.24 
The application of biodegradable polymeric NPs for drug 
delivery has been gaining momentum and shows signiﬁcant 
therapeutic potential.25–27
In our research group PELA microspheres used as drug 
delivery systems have been widely studied, from the prepara-
tion method to the factors influencing the in vitro degradation 
proﬁles and in vitro drug release proﬁles.13,28 However, the 
biological evaluation for PELA microspheres was rarely 
referred to in our previous report. In this paper, four kinds 
of microspheres based on biodegradable polymers such as 
PLA, and PELA with PEG content of 10%, 20%, or 30%, 
were prepared by a double emulsion-solvent evaporation 
technique to investigate cytotoxicity and phagocytosis. Here 
the abbreviations PELA10, PELA20, and PELA30 stand for 
PELA with PEG content of 10%, 20%, and 30%, respectively. 
In addition, PELA10 particles with an average size of 1 µm 
and 10 µm were also prepared to study the effect of particle 
size on the endocytosis in osteoblast cells.
Materials and methods
Materials
Poly(d, l-lactide) (PLA) and poly-d, l-lactide-poly(ethylene 
glycol) (PELA) with PEG weight ratios of 10%, 20%, and 
30% and molecular weight (Mw) of 4 kDa were synthesized 
by ring-opening polymerization in our laboratory as our 
previous report.14 The Mw and its distribution were mea-
sured with gel permeation chromatograph (GPC, Waters 
ALC/GPC 244, USA) using polystyrene as standards. 
Polyvinyl alcohol (PVA, Mn of 130,000 g⋅mol–1, degree of 
hydrolysis 88) was purchased from Shanghai Petrochemical 
Industry Company (China). 3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) was purchased 
from Sigma. The cells were obtained from the neonatal 
mandibular osteoblasts of a rat. All the chemicals used in 
this research were of analytical reagent grade from the com-
mercial market and have not been further puriﬁed.
Fabrication of PeLA particles
Both microspheres and nanoparticles were prepared by 
double emulsion method (W/O/W) based on solvent evapo-
ration.13 Here, we fabricated the particles with micro/nano 
scaled sizes by adjusting the stirring speed and PVA concen-
trations. Briefly, 0.1 g PLA or PELA was dissolved in 5 mL 
mixed solution (methylene chloride: acetone = 1:4 v/v) and 
emulsiﬁed with 500 µL of FITC as a fluorescent marker under 
stirring for 15 minutes at 700 rpm to form a stable initial 
emulsion. The resulting emulsion was then added dropwise 
into 50 mL 3% PVA solution and emulsiﬁed for 1 hour at 
1000 rpm using overhead whisk (R-S, Shanghai Shenshun 
Biotechnology Company, China) to form a double emul-
sion system. Finally, 10 mL 1% isopropanol solution was 
poured into the double emulsion and stirred for about 6 hours 
in fuming cupboard. After the organic solvent evaporated 
completely, the particles were collected by centrifugation 
(AvantiTM J-301, Beckman Coulter, USA) at 15,000 rpm. 
The resultant particles were rinsed with distilled water and 
centrifuged three more times, then lyophilized overnight 
and stored at 4 °C.
characterization of these particles
The mean size and distribution of these microspheres as 
determined using a laser diffraction particle size analyzer 
(LA-920, Horiba, Japan). Microspheres were resuspended 
in distilled water and ultrasonic to prevent microspheres 
aggregation. The microsphere solution was then poured 
into the sample tank of particle size analyzer. The mean 
size and size distribution of the nanoparticles (1.0 mg/mL) 
were determined by dynamic light scattering (DLS) using a 
Zeta-Sizer, Malvern Nano-ZS90 (Malvern Ltd., Malvern, 
UK). Each measurement was also repeated three times and 
the average value reported.
The surface morphology of the particles was examined 
by SEM (FEI, Quanta 200) and AFM (CSPM 5000, China). 
Several solution droplets containing particles were placed 
on the SEM sample stage. The properties of the nano-
spheres were also measured by tapping-mode atomic force International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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  microscopy (AFM) (CSPM5000, Being, China). The AFM 
sample was prepared by casting a dilute micelles solution on 
a solid silicon piece, which was then dried under vacuum. 
AFM technique is an effective, widely applied method for 
obtaining surface morphological information.30 Tapping 
mode atomic force microscopy is a technique for measur-
ing the   topography and properties of surfaces involving a 
microcantilever with a tip at one end that is excited into an 
oscillation near its resonance frequency. The cantilever-tip 
assembly is positioned vertically such that the tip touches the 
surface at the bottom of its down-stroke and is then scanned 
over the surface. The oscillation of the cantilever is affected 
by the topography of the surface, the local surface properties, 
and the feed back controller, which maintains the amplitude 
of the oscillation at a ﬁxed set-point value. The vertical move-
ments of the stage needed to maintain constant oscillation 
amplitude are used to draw the topography image and the 
phase lag of the oscillation relative to the excitation force is 
used to draw the phase image.
cytotoxicity assay
The cytotoxicity of the particles was evaluated using an 
MTT assay and flow cytometry. OBs from SD rat were 
cultured in Dulbecco’s modiﬁed Eagle’s medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) at 37 °C   
in a 5% CO2 incubator. Cells were seeded in 24-well plates 
in 2 mL medium per well at a density of 10,000 cells/well for 
6 hours. The medium was then replaced with 2 mL of medium-
  containing particles at 0.3 mg/mL and 0.6 mg/mL30 and incu-
bated for 24 hours under 5% CO2 at 37 °C. After 24 hours, 
the culture medium was removed from cell monolayers and 
cultured in 96-well plates. Each well was reconstituted with 
0.2 mL supplemented RPMI-1640 containing 1 mg/mL 
MTT and incubated the cultures for 2–4 hours at 37 °C. The 
supernatants were removed from the wells, and then 0.2 mL 
dimethyl sulfoxide (DMSO) per well was added in isopro-
panol and mixed with the content of the wells thoroughly. 
Finally, the plates were read in an automated microplate 
spectrophotometer (ELX800 Biotek, USA) at 570 nm as 
reference. Every 24 hours the same tests was performed as 
mentioned above until 72 hours. Cell viability was deter-
mined by the following formula:
Cell viability(%) =
OD (test well)
OD (reference well)
×100%
In vitro compatibility of the blank nanoparticles was 
also determined by MTT assays using OBs. All the results 
obtained from MTT assays were conﬁrmed by repeating 
the experiment on at least three independent occasions and 
testing in triplicate each time.
The flow cytometer employed was a Coulter EPICS-XL 
(Coulter, Miami, FL, USA). The cells were seeded in 6-well 
plates in 2 mL medium per well at a density of 10,000 cells/
well for 6 hours for flow cytometry. The medium was then 
replaced with 2 mL of medium-containing particles at 
0.3 mg/mL and incubated under 5% CO2 at 37 °C. When the 
amount of the cells reached 105 or more for each sample, the 
cells were gathered and frozen for preservation.31
endocytosis of nanospheres in OBs
OBs from SD rat were seeded in 12-well plates (Falcon®, 
Becton Dickinson) in 2 mL medium per well at a density of 
50,000 cells/well for 6 hours. The medium was then replaced 
with 2 mL of medium-containing nanospheres and incubated 
under 5% CO2 at 37 °C. The time-dependent cellular uptake 
of nanoparticles was further determined. To study it, cells 
were incubated with a suspension of nanoparticles (100 µg/
mL) for different time periods. The endocytosis nanospheres 
in OBs were studied using fluorescence microscope. A 
quantitative analysis of the nanoparticles level was used to 
follow endocytosis of nanoparticles by fluorescence spectro-
photometer.32 The fluorescent solutions with predetermined 
concentrations were employed to establish the standard 
curves, and subsequently, we could obtain the fluorescence 
intensity inside the particles, which further reflected the 
endocytosis of nanospheres in OBs.
Intracellular translocation studies
The cell culture was incubated with nanoparticles 
(25 µg/mL) for 12 hours at 37 °C. After washing three 
times with PBS, the cells were collected by centrifugation 
and subsequently ﬁxed with 3% glutaraldehyde for 2 hours at 
4 °C, and ﬁnally treated by osmium tetroxide for 30 minutes. 
The sample was dehydrated using a graded acetone series. 
The cells were placed in a pure acetone and Epon812 
epoxy, respectively, for 30 minutes and then embedded in 
Epon812 epoxy at 60 °C for 48 hours. Ultrathin (70 nm) 
sections were cut with a diamond knife and stained with 
lead and uranium. The sample was examined using TEM 
(Hitachi H-7650).
statistical analysis
Statistical analysis was performed using SPSS version 13.0. 
ANOVA was used to analyze statistical comparisons between 
groups. The level of signiﬁcance was set at P , 0.05.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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Results and discussion
characterization of the particles
All particles were prepared by double emulsion method 
(W/O/W) based on solvent evaporation.28 Our research 
group has previous experience with preparing nano- and 
micro-scaled particles. The average size of the particles 
can be controlled by adjusting the monomer ratio in copo-
lymers’ backbone and altering the parameters of preparation 
technology.13,28 Here, based on our previous research, the 
particles with different average size were easily fabricated. 
  Figure 1A displays the mean diameter and its polydisper-
sity (Pdi) of the particles. PLA-n, PELA10-n, PELA20-n, 
PELA30-n denote nanospheres while PELA10-1, PELA10-10 
represent the microspheres with real average size of 1.85 and 
9.92 µm, respectively, as shown in Figure 1A. The average 
diameters of PLA-n, PELA10-n, PELA20-n, and PELA30-n 
are 207 ± 21 nm, 208 ± 8 nm, 202 ± 17 nm, and 183 ± 12 nm, 
respectively (Figure 1B).
Typical scanning electron micrographs (SEM) (Figure 2) 
illustrate that all particles have a characteristic round shape 
and take on a good dispersion. The diameter and distribution 
of the particles are very consistent with the result detected 
by the laser diffraction particle size analyzer (Figure 1B). 
Meanwhile, PLA-n, PELA10-n, PELA20-n, and PELA30-n 
are further observed by AFM (Figure 3), which also indicate 
that they have excellent dispersibility in aqueous system and 
good spherical morphology.
cytotoxicity assay of the particles
PELA is widely used in drug delivery system because 
of its good biocompatibility. The main purpose in this 
experiment was to study the treatment of bone diseases. So 
osteoblast cells were used to assess cellular cytotoxicity of 
PELA   copolymer in form of particles. Following 6 hours 
of exposure to the particles, cell viability was assessed by 
the MTT assay. The results were plotted onto a ﬁtted curve 
and expressed as treatment over control (T/C) values for 
cell survival. Both nano- and micro-particles did not cause 
signiﬁcant cytotoxicity and cells had a normal shape as 
observed through inverted light microscope (Figure 4a). In 
addition, the letters A, B, C, D, E, and F were used to represent 
PLA-n, PELA10-n, PELA20-n, PELA30-n, PELA10-1, and 
PELA10-10, respectively. From Figure 4a, it can be seen that 
osteoblasts in the nanosphere groups have a better growth 
compared to the microspheres group in the original period of 
3 days of incubation, which indicates that these nanospheres 
are more biocompatible. In the microspheres group there 
are many particles in the culture medium. It can be seen 
that more and more particles are aggregated from days 1 to 
3 of incubation. This could indicate that microspheres are 
hardly phagocytized due to their large size. Figure 4b shows 
that for all nanosphere groups, as the PEG content in the 
polymer increased, the cell viability also increased from 1 to 
3 days (P , 0.05). The cell viability of PELA30-n group was 
about 85% while the others were near 80% on the ﬁrst day. 
It demonstrates that PELA30-n has a better biocompatibil-
ity compared to the other nanospheres. The reason may be 
that with the increase of PEG content in the copolymer, the 
amount of particles phagocytized by the cells was decreased, 
which resulted in less cell cytotoxicity. The mechanism may 
be that PEG interacts with the cell membrane probably by 
association with its phospholipids, and this interaction may 
stabilize the membrane.24 For these particles with the same 
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Figure 2 Morphology of particles detected by seM. A, B, c, D, e, and F denote 
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polymer (PELA10-1 and PELA10-10), it can be deduced that 
as the size and concentration of these particles increased, cell 
survival was reduced. It has been reported that the particle 
concentration influences cell survival.34 With the increase in 
size, the cell phagocytosis reduced but in the culture medium 
and the microspheres may be aggregated, which causes the 
concentration around osteoblast to be higher. Consequently, 
cell survival was 5%–10% lower than that of other particles 
at the same period. These results were also demonstrated 
through flow cytometry.
To support the MTT data further, flow cytometry was also 
employed. In the experiment, the cells were seeded in 6-well 
plates in 2 mL medium per well at a density of 10,000 cells/ 
well for 6 hours. The medium was then replaced with 2 mL 
of medium-containing particles at 0.3 mg/mL and incu-
bated under 5% CO2 at 37 °C. When the amount of cells 
reached 105 or more, the cells were gathered. In Figure 5A, 
B, C, D, E, and F represent the same as those in Figure 4. 
As shown in Figure 5A, there appeared to be two peaks in 
each ﬁgure from 1 to 3 days. Gates were set to distinguish 
the staining of the cells in the gates and all cells, which was 
measured as mean fluorescence intensity (MFI) and peak 
position of fluorescence intensity or relative number of 
positive cells (%), depending on the agent.32 Simultaneously, 
from the data in Figure 5A, both the amount of total cells 
and the cell apoptosis can be calculated. It can also be seen 
that the amount of cell apoptosis in the microsphere groups 
was generally higher than those in the nanosphere groups at 
the same time. Figure 5B shows the cell apoptosis rate derived 
from flow cytometry. The peak position of fluorescence inten-
sity of the cells in population of the cell apoptosis stained 
with PI was 14.1 ± 0.7, 15.6 ± 1.21, 10.9 ± 0.3, 10.8 ± 0.28, 
15.9 ± 1.06, and 21.7 ± 1.04, respectively, after 24 hours, and 
9.6 ± 0.54, 6.2 ± 2.13, 7.1 ± 0.14, 5 ± 1.31, 8.7 ± 0.5, and 
14.5 ± 0.82, respectively, after 48 hours, and 8.3 ± 0.85, 
3.7 ± 0.24, 3.7 ± 0.096, 3.7 ± 0.4, 7.4 ± 0.34, and 10.4 ± 0.83, 
  respectively, after 72 hours (Figure 5B). Incubated from 
1 to 3 days, the cell apoptosis rate decreased gradually. The 
results were in strong agreement with those gained in the 
MTT assay.
endocytosis of the nanospheres in OBs
In recent years, nanoparticles have attracted attention for 
use as delivery vehicles for therapeutic drugs since they can 
be designed to slip between intercellular spaces, enter cells, 
or transport directly through biological barriers to access 
disease sites.1,34 Particles loaded with fluorescent dyes are 
frequently used to study cellular uptake.33 So FITC was 
loaded in the nanospheres. Figure 6A shows the cellular 
uptake of PLA-n, PELA10-n, PELA20-n, and PELA30-n. 
As FITC was assumed to disperse evenly in the particles, the 
fluorescence intensity was linearly proportional to the amount 
of particles in the cells. So the amount of cellular uptake was 
given at each time point by testing the fluorescence intensity. 
The time-  dependent increase of uptake was observed for all 
nanoparticles between 2 to 24 hours of incubation. Nanopar-
ticle uptake was relatively rapid during the original 2 hours 
of incubation from slope rate of curve. PELA30-n showed 
the lowest uptake dose while PLA-n had the highest uptake 
dose. PELA10-n and PELA20-n were engulfed into cells of 
a similar amount. It can be seen that from 0 to 24 hours, the 
number of nanoparticles phagocytized by cells was   signiﬁcant 
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different. The reason may be that the nanospheres were recog-
nized with difﬁcultly as a foreign body by osteoblasts due to 
existence of the hydrophilic PEG. Due to the   hydrophilicity 
of PEG, the nanoparticles may be adhered to osteoblasts 
  difﬁcultly. So the number of nanospheres phagocytized is low. 
Cells would prefer to attach to more hydrophobic   polymers 
and PEG causes the polymer of choice to render the surfaces 
of particles repellent to the adsorption of proteins and resistant 
to cellular recognition. Another aspect is the decoration of 
the PEGylated surfaces with suitable ligands for cell-speciﬁc 
recognition and targeting.35,36 These results were further 
  supported by fluorescence microscopy observation.
Fluorescence micrographs of osteoblasts indicated that 
nanoparticle uptake was an endocytic process. To follow the 
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dynamics of intracellular uptake of nanoparticles, we took a 
series of fluorescence micrographs after these nanoparticles 
were dispersed in the cell culture (Figure 6B). It showed the 
microscopic images of osteoblast cells incubated with PLA, 
PELA10, PELA20, and P  ELA30 nanoparticles with 0, 2, 8, 
and 16 hours at 37 °C. It can be observed that more particles 
were engulfed with time prolongation. Since the nanopar-
ticles were added as a concentrated stock suspension on the 
top of the cell in the medium, the background fluorescence 
appears to be increasing as the particles are dispersing in the 
medium. A series of images were recorded at the different 
time points to illustrate that as the PEG content increased, 
the content of nanoparticles in osteoblast was reduced. Most 
PLA-n and PELA10-n were engulfed before 8 hours com-
pared to PELA20-n and PELA30-n. In terms of the single 
cell, there was a difference in the fluorescence intensity. This 
may be because the fluorescence intensity reflected the whole 
situation, and the different nanoparticles were phagocytized 
between 2 and 8 hours. The existence of PEG in nanoparticles 
can lead to nanoparticles being difﬁcult to be phagocytized. 
PEG interacts with the cell membrane probably by association 
with its phospholipids, and this interaction may stabilize the 
membrane, so the nanospheres were not always   recognized 
as foreign bodies by osteoblasts.
In the treatment of disease, the cellular uptake of the 
nanoparticles is also an important attribution because small 
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molecular drugs entrapped in the nanoparticles can enter 
the cells through endocytosis rather than passive diffusion.35 
Therefore, cellular uptake efﬁciency of drug-loaded nanopar-
ticles affects the therapeutic effects. From Figure 4A, these 
nanosphere groups display the highest uptake dose while the 
microsphere group has the lowest uptake dose. The reason may 
be that the particles with smaller size (200 nm) were phago-
cytized easily by osteoblast compared to the particles with 
larger size (1 and 10 µm). It could prove that osteoblasts have 
selective   phagocytosis depending on the size of foreign body. 
From Figure 6, it was found that the cellular uptake of PLA-n 
was the most efﬁcient at all time points while the cellular 
uptake proportion of PELA30-n was the lowest. A number 
of factors have been reported as influencing the uptake 
efﬁciency of nanoparticles including particle size,37 cell lines 
and cell densities, hydrophilic proportion of copolymers, and 
surface charge.38 According to our study results, particle size 
was found to be the main character in determining the cellular 
uptake efﬁciency. Moreover, the hydrophilic proportion of 
the nanoparticles also had an effect on the uptake dose, as 
PLA-n, PELA10-n, PELA20-n, and PELA30-n (similar in 
particle size but different in the hydrophilic ratio) exhibited 
different uptake proportion.
Generally, the cellular uptake of nanoparticles is com-
pleted by enclosing them into endosomes. The early endo-
somes mature into late endosomes or multivesicular bodies, 
and then to lysosomes, which accompanies a signiﬁcant 
drop in pH.39,40 Next, the intracellular fate of these nanopar-
ticles was inspected by TEM. As shown in the TEM images 
(Figure 7), some of the nanoparticles could be localized in 
the endosomes and lysosomes. Around the cell membrane, 
it can be seen that some organelles were emerging inside of 
which have nanospheres. More nanospheres could be found 
inside the cell.
Conclusions
In this study micro- and nanospheres were prepared 
using PLA, PELA10, PELA20, and PELA30 polymers as 
the matrix. The particles with average diameter of about 
200 nm, 1.85 µm, and 9.92 µm were obtained using the 
W/O/W emulsion method. The cytotoxicity of particles 
with different sizes and PEG contents were investigated 
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Figure 6 A) Fluorescence intensity of nanospheres in osteoblasts detected by 
fluorescence  spectrophotometer.  B)  Fluorescent  microscopy  utilized  to  assess 
cellular uptake of nanospheres as a function of incubation time (0.3 mg/mL, 37 °c). 
Osteoblasts were incubated with the nanospheres under the condition as indicated 
above each image, and samples were prepared for fluorescence microscope (×200) 
investigation. Bars = 20 µm.
Figure 7 TeM photo showing intracellular fate of nanospheres. some nanospheres 
were localized in endosomes and lysosomes.
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endocytosis and cytotoxicity in osteoblast cells
using MTT assay and flow cytometry. Results indicated 
that as the PEG content in the polymer increased, cell 
  survival also increased. In particular PELA30 polymers 
had a better cell compatibility compared to the other 
materials. For the same polymer, when the size and con-
centration of the particles were increased, cell survival 
was reduced. The intracellular uptake and retention of 
nanoparticles were further performed in osteoblasts. The 
fluorescence data illustrated that as the PEG content in 
the polymer increased, the content of nanoparticles in the 
osteoblast was reduced. Therefore, the nanoparticulate 
delivery system would be useful in exploring nanopar-
ticles for intracellular delivery of therapeutic agents, as 
they promise to overcome many of the obstacles inher-
ently associated with the administration of certain drugs, 
  vaccines, plasmid DNA, and RNAi.41–45
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